aluates Reports

$ 0.0

Automative

Global Respiratory Distress Syndrome Market Research Report 2026

Published Date: 2026-03-03

Report Code: QYRE-Auto-30X5534

Global Respiratory Distress Syndrome Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Respiratory Distress Syndrome Market Research Report 2026

Q: How fast is Respiratory Distress Syndrome Market growing?

The Respiratory Distress Syndrome Market witnessing a CAGR of 5.5% during the forecast period 2026-2032.

Q: What is the Respiratory Distress Syndrome Market size in 2032?

The Respiratory Distress Syndrome Market size in 2032 will be US$ 638 million.

Q: What is the Respiratory Distress Syndrome Market share by region?

North America is the largest consumption place, with a consumption market share nearly 33% .

Q: What is the market share of major companies in Respiratory Distress Syndrome Market?

Top 3 companies occupied about 85% market share.

Q: Who are the main players in the Respiratory Distress Syndrome Market report?

The main players in the Respiratory Distress Syndrome Market are Chiesi Farmaceutici, CR-Double Crane, ONY Biotech, AbbVie, Yuhan Corporation, JW Pharmaceuticals, Noargen

Q: What are the Application segmentation covered in the Respiratory Distress Syndrome Market report?

The Applications covered in the Respiratory Distress Syndrome Market report are Very Preterm Infants, Moderate to Late Preterm Infants, Others

Q: What are the Type segmentation covered in the Respiratory Distress Syndrome Market report?

The Types covered in the Respiratory Distress Syndrome Market report are Poractant Alfa, Beractant, Calfactant, Others

Code: QYRE-Auto-30X5534

Report

2026-03-03

Pages:107

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Chiesi Farmaceutici

CR Double-Crane

ONY Biotech

AbbVie

Yuhan Corporation

JW Pharmaceuticals

Noargen

Respiratory Distress Syndrome Market Size

The global Respiratory Distress Syndrome market was valued at US$ 441 million in 2025 and is anticipated to reach US$ 638 million by 2032, at a CAGR of 5.5% from 2026 to 2032.

Respiratory Distress Syndrome Market

Respiratory distress syndrome is caused by pulmonary surfactant deficiency in the lungs of neonates, most commonly in those born at < 37 weeks’ gestation. Risk increases with degree of prematurity. Symptoms and signs include grunting respirations, use of accessory muscles, and nasal flaring appearing soon after birth. Diagnosis is clinical; prenatal risk can be assessed with tests of fetal lung maturity. Treatment is surfactant therapy and supportive care. Treatment for RDS usually begins as soon as a newborn is born, sometimes in the delivery room. Treatments for RDS include surfactant replacement therapy, breathing support from a ventilator or nasal continuous positive airway pressure (NCPAP) machine, or other supportive treatments.

North America is the largest consumption place, with a consumption market share nearly 33% . Following North America, China is the second largest consumption place with the consumption market share of 26%.The key manufacturers are Chiesi Farmaceutici, CR-Double Crane, ONY Biotech, AbbVie, Yuhan Corporation, JW Pharmaceuticals, Noargen etc. Top 3 companies occupied about 85% market share.

This report delivers a comprehensive overview of the global Respiratory Distress Syndrome market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Respiratory Distress Syndrome. The Respiratory Distress Syndrome market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Respiratory Distress Syndrome market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Respiratory Distress Syndrome manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Respiratory Distress Syndrome Market Report

Report Metric	Details
Report Name	Respiratory Distress Syndrome Market
Accounted market size in 2025	US$ 441 in million
Forecasted market size in 2032	US$ 638 million
CAGR	5.5%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Poractant Alfa Beractant Calfactant Others
Segment by Application	Very Preterm Infants Moderate to Late Preterm Infants Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Chiesi Farmaceutici, CR-Double Crane, ONY Biotech, AbbVie, Yuhan Corporation, JW Pharmaceuticals, Noargen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Respiratory Distress Syndrome companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Respiratory Distress Syndrome Market growing?

Ans: The Respiratory Distress Syndrome Market witnessing a CAGR of 5.5% during the forecast period 2026-2032.

What is the Respiratory Distress Syndrome Market size in 2032?

Ans: The Respiratory Distress Syndrome Market size in 2032 will be US$ 638 million.

What is the Respiratory Distress Syndrome Market share by region?

Ans: North America is the largest consumption place, with a consumption market share nearly 33% .

What is the market share of major companies in Respiratory Distress Syndrome Market?

Ans: Top 3 companies occupied about 85% market share.

Who are the main players in the Respiratory Distress Syndrome Market report?

Ans: The main players in the Respiratory Distress Syndrome Market are Chiesi Farmaceutici, CR-Double Crane, ONY Biotech, AbbVie, Yuhan Corporation, JW Pharmaceuticals, Noargen

What are the Application segmentation covered in the Respiratory Distress Syndrome Market report?

Ans: The Applications covered in the Respiratory Distress Syndrome Market report are Very Preterm Infants, Moderate to Late Preterm Infants, Others

What are the Type segmentation covered in the Respiratory Distress Syndrome Market report?

Ans: The Types covered in the Respiratory Distress Syndrome Market report are Poractant Alfa, Beractant, Calfactant, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Respiratory Distress Syndrome Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Poractant Alfa

1.2.3 Beractant

1.2.4 Calfactant

1.2.5 Others

1.3 Market by Application

1.3.1 Global Respiratory Distress Syndrome Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Very Preterm Infants

1.3.3 Moderate to Late Preterm Infants

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Respiratory Distress Syndrome Market Perspective (2021–2032)

2.2 Global Respiratory Distress Syndrome Growth Trends by Region

2.2.1 Global Respiratory Distress Syndrome Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Respiratory Distress Syndrome Historic Market Size by Region (2021–2026)

2.2.3 Respiratory Distress Syndrome Forecasted Market Size by Region (2027–2032)

2.3 Respiratory Distress Syndrome Market Dynamics

2.3.1 Respiratory Distress Syndrome Industry Trends

2.3.2 Respiratory Distress Syndrome Market Drivers

2.3.3 Respiratory Distress Syndrome Market Challenges

2.3.4 Respiratory Distress Syndrome Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Respiratory Distress Syndrome Players by Revenue

3.1.1 Global Top Respiratory Distress Syndrome Players by Revenue (2021–2026)

3.1.2 Global Respiratory Distress Syndrome Revenue Market Share by Players (2021–2026)

3.2 Global Top Respiratory Distress Syndrome Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Respiratory Distress Syndrome Revenue

3.4 Global Respiratory Distress Syndrome Market Concentration Ratio

3.4.1 Global Respiratory Distress Syndrome Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Respiratory Distress Syndrome Revenue in 2025

3.5 Global Key Players of Respiratory Distress Syndrome Head Offices and Areas Served

3.6 Global Key Players of Respiratory Distress Syndrome, Products and Applications

3.7 Global Key Players of Respiratory Distress Syndrome, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Respiratory Distress Syndrome Breakdown Data by Type

4.1 Global Respiratory Distress Syndrome Historic Market Size by Type (2021–2026)

4.2 Global Respiratory Distress Syndrome Forecasted Market Size by Type (2027–2032)

5 Respiratory Distress Syndrome Breakdown Data by Application

5.1 Global Respiratory Distress Syndrome Historic Market Size by Application (2021–2026)

5.2 Global Respiratory Distress Syndrome Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Respiratory Distress Syndrome Market Size (2021–2032)

6.2 North America Respiratory Distress Syndrome Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Respiratory Distress Syndrome Market Size by Country (2021–2026)

6.4 North America Respiratory Distress Syndrome Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Respiratory Distress Syndrome Market Size (2021–2032)

7.2 Europe Respiratory Distress Syndrome Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Respiratory Distress Syndrome Market Size by Country (2021–2026)

7.4 Europe Respiratory Distress Syndrome Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Respiratory Distress Syndrome Market Size (2021–2032)

8.2 Asia-Pacific Respiratory Distress Syndrome Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Respiratory Distress Syndrome Market Size by Region (2021–2026)

8.4 Asia-Pacific Respiratory Distress Syndrome Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Respiratory Distress Syndrome Market Size (2021–2032)

9.2 Latin America Respiratory Distress Syndrome Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Respiratory Distress Syndrome Market Size by Country (2021–2026)

9.4 Latin America Respiratory Distress Syndrome Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Respiratory Distress Syndrome Market Size (2021–2032)

10.2 Middle East & Africa Respiratory Distress Syndrome Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Respiratory Distress Syndrome Market Size by Country (2021–2026)

10.4 Middle East & Africa Respiratory Distress Syndrome Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Chiesi Farmaceutici

11.1.1 Chiesi Farmaceutici Company Details

11.1.2 Chiesi Farmaceutici Business Overview

11.1.3 Chiesi Farmaceutici Respiratory Distress Syndrome Introduction

11.1.4 Chiesi Farmaceutici Revenue in Respiratory Distress Syndrome Business (2021–2026)

11.1.5 Chiesi Farmaceutici Recent Development

11.2 CR-Double Crane

11.2.1 CR-Double Crane Company Details

11.2.2 CR-Double Crane Business Overview

11.2.3 CR-Double Crane Respiratory Distress Syndrome Introduction

11.2.4 CR-Double Crane Revenue in Respiratory Distress Syndrome Business (2021–2026)

11.2.5 CR-Double Crane Recent Development

11.3 ONY Biotech

11.3.1 ONY Biotech Company Details

11.3.2 ONY Biotech Business Overview

11.3.3 ONY Biotech Respiratory Distress Syndrome Introduction

11.3.4 ONY Biotech Revenue in Respiratory Distress Syndrome Business (2021–2026)

11.3.5 ONY Biotech Recent Development

11.4 AbbVie

11.4.1 AbbVie Company Details

11.4.2 AbbVie Business Overview

11.4.3 AbbVie Respiratory Distress Syndrome Introduction

11.4.4 AbbVie Revenue in Respiratory Distress Syndrome Business (2021–2026)

11.4.5 AbbVie Recent Development

11.5 Yuhan Corporation

11.5.1 Yuhan Corporation Company Details

11.5.2 Yuhan Corporation Business Overview

11.5.3 Yuhan Corporation Respiratory Distress Syndrome Introduction

11.5.4 Yuhan Corporation Revenue in Respiratory Distress Syndrome Business (2021–2026)

11.5.5 Yuhan Corporation Recent Development

11.6 JW Pharmaceuticals

11.6.1 JW Pharmaceuticals Company Details

11.6.2 JW Pharmaceuticals Business Overview

11.6.3 JW Pharmaceuticals Respiratory Distress Syndrome Introduction

11.6.4 JW Pharmaceuticals Revenue in Respiratory Distress Syndrome Business (2021–2026)

11.6.5 JW Pharmaceuticals Recent Development

11.7 Noargen

11.7.1 Noargen Company Details

11.7.2 Noargen Business Overview

11.7.3 Noargen Respiratory Distress Syndrome Introduction

11.7.4 Noargen Revenue in Respiratory Distress Syndrome Business (2021–2026)

11.7.5 Noargen Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Chiesi Farmaceutici

CR Double-Crane

ONY Biotech

AbbVie

Yuhan Corporation

JW Pharmaceuticals

Noargen

List of Tables

Table 1. Global Respiratory Distress Syndrome Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Poractant Alfa

Table 3. Key Players of Beractant

Table 4. Key Players of Calfactant

Table 5. Key Players of Others

Table 6. Global Respiratory Distress Syndrome Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Respiratory Distress Syndrome Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Respiratory Distress Syndrome Market Size by Region (US$ Million), 2021–2026

Table 9. Global Respiratory Distress Syndrome Market Share by Region (2021–2026)

Table 10. Global Respiratory Distress Syndrome Forecasted Market Size by Region (US$ Million), 2027–2032

Table 11. Global Respiratory Distress Syndrome Market Share by Region (2027–2032)

Table 12. Respiratory Distress Syndrome Market Trends

Table 13. Respiratory Distress Syndrome Market Drivers

Table 14. Respiratory Distress Syndrome Market Challenges

Table 15. Respiratory Distress Syndrome Market Restraints

Table 16. Global Respiratory Distress Syndrome Revenue by Players (US$ Million), 2021–2026

Table 17. Global Respiratory Distress Syndrome Market Share by Players (2021–2026)

Table 18. Global Top Respiratory Distress Syndrome Players by Tier (Tier 1, Tier 2, and Tier 3), based on Respiratory Distress Syndrome Revenue, 2025

Table 19. Ranking of Global Top Respiratory Distress Syndrome Companies by Revenue (US$ Million) in 2025

Table 20. Global 5 Largest Players Market Share by Respiratory Distress Syndrome Revenue (CR5 and HHI), 2021–2026

Table 21. Global Key Players of Respiratory Distress Syndrome, Headquarters and Area Served

Table 22. Global Key Players of Respiratory Distress Syndrome, Products and Applications

Table 23. Global Key Players of Respiratory Distress Syndrome, Date of General Availability (GA)

Table 24. Mergers and Acquisitions, Expansion Plans

Table 25. Global Respiratory Distress Syndrome Market Size by Type (US$ Million), 2021–2026

Table 26. Global Respiratory Distress Syndrome Revenue Market Share by Type (2021–2026)

Table 27. Global Respiratory Distress Syndrome Forecasted Market Size by Type (US$ Million), 2027–2032

Table 28. Global Respiratory Distress Syndrome Revenue Market Share by Type (2027–2032)

Table 29. Global Respiratory Distress Syndrome Market Size by Application (US$ Million), 2021–2026

Table 30. Global Respiratory Distress Syndrome Revenue Market Share by Application (2021–2026)

Table 31. Global Respiratory Distress Syndrome Forecasted Market Size by Application (US$ Million), 2027–2032

Table 32. Global Respiratory Distress Syndrome Revenue Market Share by Application (2027–2032)

Table 33. North America Respiratory Distress Syndrome Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 34. North America Respiratory Distress Syndrome Market Size by Country (US$ Million), 2021–2026

Table 35. North America Respiratory Distress Syndrome Market Size by Country (US$ Million), 2027–2032

Table 36. Europe Respiratory Distress Syndrome Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 37. Europe Respiratory Distress Syndrome Market Size by Country (US$ Million), 2021–2026

Table 38. Europe Respiratory Distress Syndrome Market Size by Country (US$ Million), 2027–2032

Table 39. Asia-Pacific Respiratory Distress Syndrome Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 40. Asia-Pacific Respiratory Distress Syndrome Market Size by Region (US$ Million), 2021–2026

Table 41. Asia-Pacific Respiratory Distress Syndrome Market Size by Region (US$ Million), 2027–2032

Table 42. Latin America Respiratory Distress Syndrome Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. Latin America Respiratory Distress Syndrome Market Size by Country (US$ Million), 2021–2026

Table 44. Latin America Respiratory Distress Syndrome Market Size by Country (US$ Million), 2027–2032

Table 45. Middle East & Africa Respiratory Distress Syndrome Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Middle East & Africa Respiratory Distress Syndrome Market Size by Country (US$ Million), 2021–2026

Table 47. Middle East & Africa Respiratory Distress Syndrome Market Size by Country (US$ Million), 2027–2032

Table 48. Chiesi Farmaceutici Company Details

Table 49. Chiesi Farmaceutici Business Overview

Table 50. Chiesi Farmaceutici Respiratory Distress Syndrome Product

Table 51. Chiesi Farmaceutici Revenue in Respiratory Distress Syndrome Business (US$ Million), 2021–2026

Table 52. Chiesi Farmaceutici Recent Development

Table 53. CR-Double Crane Company Details

Table 54. CR-Double Crane Business Overview

Table 55. CR-Double Crane Respiratory Distress Syndrome Product

Table 56. CR-Double Crane Revenue in Respiratory Distress Syndrome Business (US$ Million), 2021–2026

Table 57. CR-Double Crane Recent Development

Table 58. ONY Biotech Company Details

Table 59. ONY Biotech Business Overview

Table 60. ONY Biotech Respiratory Distress Syndrome Product

Table 61. ONY Biotech Revenue in Respiratory Distress Syndrome Business (US$ Million), 2021–2026

Table 62. ONY Biotech Recent Development

Table 63. AbbVie Company Details

Table 64. AbbVie Business Overview

Table 65. AbbVie Respiratory Distress Syndrome Product

Table 66. AbbVie Revenue in Respiratory Distress Syndrome Business (US$ Million), 2021–2026

Table 67. AbbVie Recent Development

Table 68. Yuhan Corporation Company Details

Table 69. Yuhan Corporation Business Overview

Table 70. Yuhan Corporation Respiratory Distress Syndrome Product

Table 71. Yuhan Corporation Revenue in Respiratory Distress Syndrome Business (US$ Million), 2021–2026

Table 72. Yuhan Corporation Recent Development

Table 73. JW Pharmaceuticals Company Details

Table 74. JW Pharmaceuticals Business Overview

Table 75. JW Pharmaceuticals Respiratory Distress Syndrome Product

Table 76. JW Pharmaceuticals Revenue in Respiratory Distress Syndrome Business (US$ Million), 2021–2026

Table 77. JW Pharmaceuticals Recent Development

Table 78. Noargen Company Details

Table 79. Noargen Business Overview

Table 80. Noargen Respiratory Distress Syndrome Product

Table 81. Noargen Revenue in Respiratory Distress Syndrome Business (US$ Million), 2021–2026

Table 82. Noargen Recent Development

Table 83. Research Programs/Design for This Report

Table 84. Key Data Information from Secondary Sources

Table 85. Key Data Information from Primary Sources

Table 86. Authors List of This Report

List of Figures

Figure 1. Respiratory Distress Syndrome Picture

Figure 2. Global Respiratory Distress Syndrome Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Respiratory Distress Syndrome Market Share by Type: 2025 vs 2032

Figure 4. Poractant Alfa Features

Figure 5. Beractant Features

Figure 6. Calfactant Features

Figure 7. Others Features

Figure 8. Global Respiratory Distress Syndrome Market Size by Application (US$ Million), 2021–2032

Figure 9. Global Respiratory Distress Syndrome Market Share by Application: 2025 vs 2032

Figure 10. Very Preterm Infants Case Studies

Figure 11. Moderate to Late Preterm Infants Case Studies

Figure 12. Others Case Studies

Figure 13. Respiratory Distress Syndrome Report Years Considered

Figure 14. Global Respiratory Distress Syndrome Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 15. Global Respiratory Distress Syndrome Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 16. Global Respiratory Distress Syndrome Market Share by Region: 2025 vs 2032

Figure 17. Global Respiratory Distress Syndrome Market Share by Players in 2025

Figure 18. Global Respiratory Distress Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 19. The Top 10 and 5 Players Market Share by Respiratory Distress Syndrome Revenue in 2025

Figure 20. North America Respiratory Distress Syndrome Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. North America Respiratory Distress Syndrome Market Share by Country (2021–2032)

Figure 22. United States Respiratory Distress Syndrome Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Canada Respiratory Distress Syndrome Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Respiratory Distress Syndrome Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Europe Respiratory Distress Syndrome Market Share by Country (2021–2032)

Figure 26. Germany Respiratory Distress Syndrome Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. France Respiratory Distress Syndrome Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. U.K. Respiratory Distress Syndrome Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Italy Respiratory Distress Syndrome Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Russia Respiratory Distress Syndrome Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Ireland Respiratory Distress Syndrome Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Respiratory Distress Syndrome Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Asia-Pacific Respiratory Distress Syndrome Market Share by Region (2021–2032)

Figure 34. China Respiratory Distress Syndrome Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Japan Respiratory Distress Syndrome Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. South Korea Respiratory Distress Syndrome Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Southeast Asia Respiratory Distress Syndrome Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. India Respiratory Distress Syndrome Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Australia & New Zealand Respiratory Distress Syndrome Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Respiratory Distress Syndrome Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Latin America Respiratory Distress Syndrome Market Share by Country (2021–2032)

Figure 42. Mexico Respiratory Distress Syndrome Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Brazil Respiratory Distress Syndrome Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Respiratory Distress Syndrome Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Middle East & Africa Respiratory Distress Syndrome Market Share by Country (2021–2032)

Figure 46. Israel Respiratory Distress Syndrome Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Saudi Arabia Respiratory Distress Syndrome Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. UAE Respiratory Distress Syndrome Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Chiesi Farmaceutici Revenue Growth Rate in Respiratory Distress Syndrome Business (2021–2026)

Figure 50. CR-Double Crane Revenue Growth Rate in Respiratory Distress Syndrome Business (2021–2026)

Figure 51. ONY Biotech Revenue Growth Rate in Respiratory Distress Syndrome Business (2021–2026)

Figure 52. AbbVie Revenue Growth Rate in Respiratory Distress Syndrome Business (2021–2026)

Figure 53. Yuhan Corporation Revenue Growth Rate in Respiratory Distress Syndrome Business (2021–2026)

Figure 54. JW Pharmaceuticals Revenue Growth Rate in Respiratory Distress Syndrome Business (2021–2026)

Figure 55. Noargen Revenue Growth Rate in Respiratory Distress Syndrome Business (2021–2026)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Acute Respiratory Distress Syndrome Treatment Device Market Research Report 2024

Neonatal Respiratory Distress Syndrome Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Bronchopulmonary Dysplasia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Medical Neonatal Ventilators Market Insights Forecast to 2030

Global Neonatal Preterm Infant Care Market Insights Forecast to 2030

Global Mechanical Neonatal Ventilators Market Insights Forecast to 2030

Preterm Birth Prevention and Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pressure Mode Neonatal Ventilators Market

Breathing Disorders Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Preterm Birth Prevention and Management Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Neonatal Noninvasive Ventilator Market Insights Forecast to 2030

Global Eisenmenger Syndrome Treatment Market Research Report 2024

Global Lung Surfactants Market Research Report 2024

Global Acute Respiratory Distress Syndrome Ventilation Treatment Device Market Research Report 2024

Global Neonatal Intensive Care Ventilators Market Insights Forecast to 2030

Global Intensive Care Neonatal Ventilators Market Insights Forecast to 2030

Neonatal Intensive Care Respiratory Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Acute Respiratory Distress Syndrome Device Market Research Report 2024

Volume Mode Neonatal Ventilators Market

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions